Journal
/
/
Induksjon av Invasive Transitional Cell blære carcinoma in Immune Intakt Menneskelige MUC1 transgene mus: En modell for Immunterapi Development
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
DOI:

11:02 min

October 30, 2013

, , , , , , ,

Chapters

  • 00:05Title
  • 01:43Bladder Cancer Induction and Vaccination Treatments
  • 02:49Monitoring and Sample Collection
  • 04:11Multiplex Fluorometric Microbead Immunoassay
  • 06:37IFN-γ/IL-4 ELISpot Preparation and Analysis
  • 08:07Representative Transitional Cell Bladder Carcinoma Induction Results
  • 10:39Conclusion

Summary

Automatic Translation

Et N-butyl-N-(4-hydroksybutyl) nitrosamin-indusert blærekreft modell ble utviklet i human mucin 1 (MUC1) transgene mus for å teste MUC1-rettet immunterapi. Etter administrering av en MUC1-målrettet peptid vaksine, ble en cytotoksisk T-lymfocytt respons på MUC1 bekreftet ved å måle serum cytokin nivåer og T-celle spesifikke aktivitet.

Related Videos

Read Article